Immuno-chemotherapy

DRUG2 trials

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University, Sun Yat-sen University

Conditions

Breast AdenocarcinomaSmall-Cell Lung Cancer (SCLC)

Phase 2

Neoadjuvant Toripalimab and Radiotherapy Treatment in N+ HR+ Breast Cancer

RecruitingNCT06671262

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityBreast Adenocarcinoma

Start: 2024-12-26End: 2027-11-01Target: 74Updated: 2025-02-11

A Study Evaluating Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade for Limited-stage Small Cell Lung Cancer

Not yet recruitingNCT07103408

Sun Yat-sen UniversitySmall-Cell Lung Cancer (SCLC)

Start: 2025-10-01End: 2029-09-30Target: 56Updated: 2025-08-05